Departments, Centers, & Programs:
Mass General Neurology
55 Fruit St.
Boston, MA 02114
- MBCHB, University of Aberdeen, School of Medicine
- Residency, Beth Israel Deaconess Hospital
- Residency, Edinburgh University Hospitals
- Fellowship, Addenbrooke's Hospital
- Fellowship, Massachusetts General Hospital
American Board Certifications
- Neurology, American Board of Psychiatry and Neurology
Accepted Insurance Plans
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
I am a neurologist clinician-scientist with a special interest in movement disorders, particularly rare neurogenetic movement disorders (dystonia, ataxias and their overlap), with substantial clinical and research expertise in this field. My current interest is in quantitative measures of motor physiology as potential novel motor biomarkers and to complement this with biochemical biomarker research. To this end, I was a principal investigator in a study of video oculography and other novel non-motor biomarkers in late-onset GM2 gangliosidosis (LOGG), which and am applying these techniques, as well as other quantitative measures to other conditions. I am a member of the MGH Collaborative Center for X-linked dystonia parkinsonism (XDP) and a lead investigator in an ongoing natural history study (TRACK-XDP). I am also a leading investigator in functional neurological disorders (FND) and a key member of the MGH FND Research Group, with several important personal and collaborative contributions. I am involved in several other research projects in dystonia, as well as in rare movement disorders, including the genetics of musician’s dystonia and the epidemiology of prodromal Parkinson’s disease (PD). Bringing potential treatments to patients, for which there are currently no cures is vital, and to address this, I am an investigator in pivotal clinical drug trials in the spinocerebellar ataxias and LOGG, as well as in rare and idiopathic causes of parkinsonism.